Who is sponsoring NCT03393871?

NCT03393871 is sponsored by Catharina Ziekenhuis Eindhoven.

What drugs are being tested in NCT03393871?

Interventions in NCT03393871: absolute blood flow measurement.

What condition does NCT03393871 study?

NCT03393871 studies Fractional Flow Reserve, Absolute Flow Measurement, FFR-CT, Myocardial Mass, Coronary Artery Disease.

Is NCT03393871 still recruiting?

NCT03393871 is currently completed. Last updated 24 July 2019.

Last reviewed 2019-07-24 · How we verify

NCT03393871: MyoMass

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Myocardial Mass Determination by FFRct and Absolute Coronary Blood Flow

Completed Last updated 24 July 2019

What this trial tests

trial testing absolute blood flow measurement in Fractional Flow Reserve in 60 participants. Completed in 1 March 2019.

Timeline

1 February 2018

Primary endpoint
1 December 2018

1 March 2019

Quick facts

Lead sponsor	Catharina Ziekenhuis Eindhoven
Status	Completed
Study type	OBSERVATIONAL
Enrollment	60
Start date	1 February 2018
Primary completion	1 December 2018
Estimated completion	1 March 2019
Sites	1 location across Netherlands

Drugs / interventions tested

absolute blood flow measurement

Conditions studied

Fractional Flow Reserve — all drugs for Fractional Flow Reserve →
Absolute Flow Measurement — all drugs for Absolute Flow Measurement →
FFR-CT — all drugs for FFR-CT →
Myocardial Mass — all drugs for Myocardial Mass →

Sponsor

Catharina Ziekenhuis Eindhoven — full company profile →

Who can join

Adults 18 to 75, any sex, with Fractional Flow Reserve or Absolute Flow Measurement. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The background for performing the present study is to compare the mass calculations by CT scanning and by invasive absolute blood flow measurements and thereby corroborating both methods.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Fractional Flow Reserve

Currently open trials in the same condition.

NCT06659367 — Dedinje FFR/QFR Registry · recruiting

Other Catharina Ziekenhuis Eindhoven trials

Trials by the same sponsor.

NCT07314138 — Multivessel Minimally Invasive Coronary Bypass Grafting as HYBRID Revascularization Versus Conventional Off-pump Coronar · NA · not yet recruiting
NCT06768060 — Mindfulness-based Intervention Prior to External Cephalic Version · NA · recruiting
NCT06574867 — Evaluation of the viQtor Monitoring Solution on Surgical Wards · recruiting
NCT06374836 — The Contractile Response of the Thoracic Aorta to Vasoactive Substances · completed
NCT06401291 — Transcutaneous Electrical Nerve Stimulation in Patients With Angina and Non-Obstructive Coronary Arteries · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03393871 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Catharina Ziekenhuis Eindhoven
Last refreshed: 24 July 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03393871.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing